Since 2009, RCDD has received the funding of approximately 18 million RMB (~3 million USD), which is supporting the following research projects:
(1) Anti-flu TCM drugs (pre-clinic trials),
(2) Anti-HBV TCM and chemical drugs (animal testing),
(3) Anti-metabolic syndrome drugs (bio-screening),
(4) Anti-ageing drugs,
(5) Anti-inflammatory drugs, and
(6) Software development for CADD
